JBC GenomeOne product landing page

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohnert, B. I.
Right arrow Articles by Bernlohr, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frohnert, B. I.
Right arrow Articles by Bernlohr, D. A.

J Biol Chem, Vol. 274, Issue 7, 3970-3977, February 12, 1999

Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene

Brigitte I. Frohnert, To Y. Hui, and David A. Bernlohr

From the Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, St. Paul, Minnesota 55108

Fatty acid transport protein (FATP), a plasma membrane protein implicated in controlling adipocyte transmembrane fatty acid flux, is up-regulated as a consequence of adipocyte differentiation and down-regulated by insulin. Based upon the sequence of the FATP gene upstream region (Hui, T. Y., Frohnert, B. I., Smith, A. J., Schaffer, J. A., and Bernlohr, D. A. (1998) J. Biol. Chem. 273, 27420-27429) a putative peroxisome proliferator-activated receptor response element (PPRE) is present from -458 to -474. To determine whether the FATP PPRE was functional, and responded to lipid activators, transient transfection of FATP-luciferase reporter constructs into CV-1 and 3T3-L1 cells was carried out. In CV-1 cells, FATP-luciferase activity was up-regulated 4- and 5.5-fold, respectively, by PPARalpha and PPARgamma in the presence of their respective activators in a PPRE-dependent mechanism. PPARdelta , however, was unable to mediate transcriptional activation under any condition. In 3T3-L1 cells, the PPRE conferred a small but significant increase in expression in preadipocytes, as well as a more robust up-regulation of FATP expression in adipocytes. Furthermore, the PPRE conferred the ability for luciferase expression to be up-regulated by activators of both PPARgamma and retinoid X receptor alpha  (RXRalpha ) in a synergistic manner. PPARalpha and PPARdelta activators did not up-regulate FATP expression in 3T3-L1 adipocytes, however, suggesting that these two subtypes do not play a significant role in differentiation-dependent activation in fat cells. Electromobility shift assays showed that all three PPAR subtypes were able to bind specifically to the PPRE as heterodimers with RXRalpha . Nuclear extracts from 3T3-L1 adipocytes also showed a specific gel-shift complex with the FATP PPRE. To correlate the expression of FATP to its physiological function, treatment of 3T3-L1 adipocytes with PPARgamma and RXRalpha activators resulted in an increased uptake of oleate. Moreover, linoleic acid, a physiological ligand, up-regulated FATP expression 2-fold in a PPRE-dependent manner. These results demonstrate that the FATP gene possesses a functional PPRE and is up-regulated by activators of PPARalpha and PPARgamma , thereby linking the activity of the protein to the expression of its gene. Moreover, these results have implications for the mechanism by which certain PPARgamma activators such as the antidiabetic thiazolidinedione drugs affect adipose lipid metabolism.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Lipid Res.Home page
H. Li, P. N. Black, A. Chokshi, A. Sandoval-Alvarez, R. Vatsyayan, W. Sealls, and C. C. DiRusso
High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias
J. Lipid Res., January 1, 2008; 49(1): 230 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. E. Kershaw, M. Schupp, H.-P. Guan, N. P. Gardner, M. A. Lazar, and J. S. Flier
PPAR{gamma} regulates adipose triglyceride lipase in adipocytes in vitro and in vivo
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1736 - E1745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. A Ruiz-Narvaez, P. Kraft, and H. Campos
Ala12 variant of the peroxisome proliferator-activated receptor-{gamma} gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1238 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Lobo, B. M. Wiczer, A. J. Smith, A. M. Hall, and D. A. Bernlohr
Fatty acid metabolism in adipocytes: functional analysis of fatty acid transport proteins 1 and 4
J. Lipid Res., March 1, 2007; 48(3): 609 - 620.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al.
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Q. Wu, M. Kazantzis, H. Doege, A. M. Ortegon, B. Tsang, A. Falcon, and A. Stahl
Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue
Diabetes, December 1, 2006; 55(12): 3229 - 3237.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Grun, H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D. M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Mol. Endocrinol., September 1, 2006; 20(9): 2141 - 2155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. K. LeBrasseur, M. Kelly, T.-S. Tsao, S. R. Farmer, A. K. Saha, N. B. Ruderman, and E. Tomas
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E175 - E181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jitrapakdee, M. Slawik, G. Medina-Gomez, M. Campbell, J. C. Wallace, J. K. Sethi, S. O'Rahilly, and A. J. Vidal-Puig
The Peroxisome Proliferator-activated Receptor-{gamma} Regulates Murine Pyruvate Carboxylase Gene Expression in Vivo and in Vitro
J. Biol. Chem., July 22, 2005; 280(29): 27466 - 27476.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. T. Schaiff, I. Bildirici, M. Cheong, P. L. Chern, D. M. Nelson, and Y. Sadovsky
Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Signaling Regulate Fatty Acid Uptake by Primary Human Placental Trophoblasts
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4267 - 4275.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. L. M. Coort, W. A. Coumans, A. Bonen, G. J. van der Vusse, J. F. C. Glatz, and J. J. F. P. Luiken
Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats
J. Lipid Res., June 1, 2005; 46(6): 1295 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. DiRusso, H. Li, D. Darwis, P. A. Watkins, J. Berger, and P. N. Black
Comparative Biochemical Studies of the Murine Fatty Acid Transport Proteins (FATP) Expressed in Yeast
J. Biol. Chem., April 29, 2005; 280(17): 16829 - 16837.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar
Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes
Genes & Dev., February 15, 2005; 19(4): 453 - 461.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Huss and D. P. Kelly
Nuclear Receptor Signaling and Cardiac Energetics
Circ. Res., September 17, 2004; 95(6): 568 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. A. Sauer, R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, E. M. Dauchy, K. J. Welham, and K. Coupland
Conjugated Linoleic Acid Isomers and Trans Fatty Acids Inhibit Fatty Acid Transport in Hepatoma 7288CTC and Inguinal Fat Pads in Buffalo Rats
J. Nutr., August 1, 2004; 134(8): 1989 - 1997.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Noon, A. J. L. Clark, and P. J. King
A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes
J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Nagai, C. Shimizu, M. Umetsu, S. Taniguchi, M. Endo, H. Miyoshi, N. Yoshioka, M. Kubo, and T. Koike
Identification of a Functional Peroxisome Proliferator-Activated Receptor Responsive Element within the Murine Perilipin Gene
Endocrinology, May 1, 2004; 145(5): 2346 - 2356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. M. Wilmsen, T. P. Ciaraldi, L. Carter, N. Reehman, S. R. Mudaliar, and R. R. Henry
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E354 - E362.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. D. Girnun, F. E. Domann, S. A. Moore, and M. E. C. Robbins
Identification of a Functional Peroxisome Proliferator-Activated Receptor Response Element in the Rat Catalase Promoter
Mol. Endocrinol., December 1, 2002; 16(12): 2793 - 2801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Blanquart, O. Barbier, J.-C. Fruchart, B. Staels, and C. Glineur
Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Turnover by the Ubiquitin-Proteasome System Controls the Ligand-induced Expression Level of Its Target Genes
J. Biol. Chem., September 27, 2002; 277(40): 37254 - 37259.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Tordjman, K. N. Standley, C. Bernal-Mizrachi, T. C. Leone, T. Coleman, D. P. Kelly, and C. F. Semenkovich
PPAR{alpha} suppresses insulin secretion and induces UCP2 in insulinoma cells
J. Lipid Res., June 1, 2002; 43(6): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Young, P. McNulty, and H. Taegtmeyer
Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms
Circulation, April 16, 2002; 105(15): 1861 - 1870.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. Campbell, R. Kozak, A. Wagner, J. Y. Altarejos, J. R. B. Dyck, D. D. Belke, D. L. Severson, D. P. Kelly, and G. D. Lopaschuk
A Role for Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) in the Control of Cardiac Malonyl-CoA Levels. REDUCED FATTY ACID OXIDATION RATES AND INCREASED GLUCOSE OXIDATION RATES IN THE HEARTS OF MICE LACKING PPARalpha ARE ASSOCIATED WITH HIGHER CONCENTRATIONS OF MALONYL-CoA AND REDUCED EXPRESSION OF MALONYL-CoA DECARBOXYLASE
J. Biol. Chem., February 1, 2002; 277(6): 4098 - 4103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kishida, I. Shimomura, H. Nishizawa, N. Maeda, H. Kuriyama, H. Kondo, M. Matsuda, H. Nagaretani, N. Ouchi, K. Hotta, et al.
Enhancement of the Aquaporin Adipose Gene Expression by a Peroxisome Proliferator-activated Receptor gamma
J. Biol. Chem., December 14, 2001; 276(51): 48572 - 48579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Minnich, N. Tian, L. Byan, and G. Bilder
A potent PPAR{alpha} agonist stimulates mitochondrial fatty acid {beta}-oxidation in liver and skeletal muscle
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E270 - E279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Sauer, R. T. Dauchy, and D. E. Blask
Mechanism for the Antitumor and Anticachectic Effects of n-3 Fatty Acids
Cancer Res., September 1, 2000; 60(18): 5289 - 5295.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. A. Baumann, N. Chokshi, A. R. Saltiel, and V. Ribon
Cloning and Characterization of a Functional Peroxisome Proliferator Activator Receptor-gamma -responsive Element in the Promoter of the CAP Gene
J. Biol. Chem., March 24, 2000; 275(13): 9131 - 9135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. R. Coe, A. J. Smith, B. I. Frohnert, P. A. Watkins, and D. A. Bernlohr
The Fatty Acid Transport Protein (FATP1) Is a Very Long Chain Acyl-CoA Synthetase
J. Biol. Chem., December 17, 1999; 274(51): 36300 - 36304.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Desvergne and W. Wahli
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Endocr. Rev., October 1, 1999; 20(5): 649 - 688.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. P. Beigneux, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver
J. Biol. Chem., May 19, 2000; 275(21): 16390 - 16399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Barbera, A. Schluter, N. Pedraza, R. Iglesias, F. Villarroya, and M. Giralt
Peroxisome Proliferator-activated Receptor alpha Activates Transcription of the Brown Fat Uncoupling Protein-1 Gene. A LINK BETWEEN REGULATION OF THE THERMOGENIC AND LIPID OXIDATION PATHWAYS IN THE BROWN FAT CELL
J. Biol. Chem., January 5, 2001; 276(2): 1486 - 1493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.